Wholehealth PLLC is a Risk Evaluation and Mitigation Strategy (REMS) certified to provide SPRAVATO™(esketamine) CIII, a nasal spray approved for use in conjunction with an oral antidepressant in adults with treatment-resistant depression (TRD). Individuals who are currently struggling with major depressive disorder (MDD) may have TRD if they have not responded adequately to at least two different antidepressants of adequate dose and duration in the current depressive episode. The treatment is FDA approved and covered by Insurance.
As a certified treatment center, our medical staff have been trained to prescribe, dispense and administer SPRAVATO™ and have established processes and procedures in accordance with the REMS. A healthcare provider will provide direct supervision as the patient self-administers SPRAVATO™ and will monitor every patient after every dose for at least two hours for resolution of sedation and dissociation and changes in vital signs. SPRAVATO™ must never be dispensed directly to a patient for home use.
Additionally, all patients will require transportation from Wholehealth PLLC following the observation period, as they should not drive or operate machinery until the day after a treatment session, following a restful sleep.
For more information regarding administration, REMS requirements, or other related questions, please contact the Office Manager.
For more detailed information and preparing for treatment: Treatment with Spravato
To view patient testimonials on Spravato: Patient Stories
For more information on SPRAVATO™, please refer to the manufacturer’s Prescribing Information and Medication Guide or visit www.SPRAVATO.com. If you are a patient, please speak to your healthcare provider for more information.
Wholehealth PLLC is located at
6100 Corporate Dr #238,
Houston, TX
77036
[recent-blogs count=5]